TOFATAS TAB

About

Tofacitinib is an oral Janus kinase (JAK) inhibitor, a type of targeted synthetic disease-modifying antirheumatic drug (tsDMARD). It works by selectively inhibiting the activity of JAK enzymes, which are intracellular enzymes involved in signaling pathways that mediate the immune response and inflammation. By blocking these pathways, tofacitinib reduces the production of inflammatory cytokines, thereby decreasing inflammation and slowing the progression of joint damage in autoimmune conditions. It is used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in patients who have not responded adequately to other therapies. Its mechanism of action offers a different approach to managing chronic inflammatory diseases compared to traditional immunosuppressants.

Uses

• Treatment of moderate to severe rheumatoid arthritis.
• Treatment of active psoriatic arthritis.
• Treatment of moderate to severe ulcerative colitis.
• Management of ankylosing spondylitis (off-label).

Directions For Use

Take the tablet orally with or without food, as directed by your physician. Do not crush, split, or chew the tablet.

Benefits

• Reduces inflammation and pain in joints.
• Slows the progression of joint damage.
• Improves physical function and quality of life.
• Effective in patients who failed other therapies.
• Oral administration offers convenience.
• Provides rapid onset of action for symptom relief.

Side Effects

• Upper respiratory tract infections
• Headache
• Diarrhea
• Nausea
• Nasopharyngitis
• Increased risk of serious infections (e.g., herpes zoster)
• Anemia
• Elevated cholesterol levels
• Elevated liver enzymes
• Increased risk of blood clots (DVT/PE)
• Lymphopenia
• Neutropenia

Safety Measures

• Alcohol - No specific interaction, but excessive alcohol can worsen liver function, which should be monitored with this medication.
• Pregnancy - Not recommended during pregnancy due to potential fetal harm; effective contraception is advised during treatment and for some time after.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk and cause serious adverse reactions in the infant.
• Liver - Use with caution in patients with liver impairment; dose adjustment may be necessary, and liver function should be monitored.
• Kidney - Use with caution in patients with moderate to severe kidney impairment; dose adjustment is typically required.
• Lung - Increased risk of serious infections, including opportunistic infections; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.